ATE208042T1 - Hapten-analoge zur verwendung in immunoassays - Google Patents

Hapten-analoge zur verwendung in immunoassays

Info

Publication number
ATE208042T1
ATE208042T1 AT92201580T AT92201580T ATE208042T1 AT E208042 T1 ATE208042 T1 AT E208042T1 AT 92201580 T AT92201580 T AT 92201580T AT 92201580 T AT92201580 T AT 92201580T AT E208042 T1 ATE208042 T1 AT E208042T1
Authority
AT
Austria
Prior art keywords
nucleus
immunoassays
hapten
analogues
hapten analogues
Prior art date
Application number
AT92201580T
Other languages
English (en)
Inventor
Susan Jean Danielson
Marsha D Oenick
Ignazio Ponticello
David Alan Hilborn
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Application granted granted Critical
Publication of ATE208042T1 publication Critical patent/ATE208042T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
AT92201580T 1991-06-07 1992-06-02 Hapten-analoge zur verwendung in immunoassays ATE208042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71232991A 1991-06-07 1991-06-07
US07/851,435 US5284948A (en) 1991-06-07 1992-03-16 Drug hapten analogues for immunoassays

Publications (1)

Publication Number Publication Date
ATE208042T1 true ATE208042T1 (de) 2001-11-15

Family

ID=27108809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92201580T ATE208042T1 (de) 1991-06-07 1992-06-02 Hapten-analoge zur verwendung in immunoassays

Country Status (5)

Country Link
US (1) US5284948A (de)
EP (1) EP0517325B1 (de)
JP (1) JP3190728B2 (de)
AT (1) ATE208042T1 (de)
DE (1) DE69232162T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents
CA2396359C (en) * 2000-01-07 2019-09-17 Monsanto Technology Llc Nucleic acid molecules and other molecules associated with soybean cyst nematode resistance
US6991911B2 (en) 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US7022492B2 (en) 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US7037669B2 (en) 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US7115383B2 (en) 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
US8133743B2 (en) * 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay
CN103364556B (zh) * 2012-04-05 2016-02-24 北京勤邦生物技术有限公司 一种检测呋喃妥因代谢物的试剂盒及方法
EP3556759B1 (de) * 2012-08-21 2023-11-29 Janssen Pharmaceutica NV Haptene von paliperidon
KR101515020B1 (ko) 2013-11-13 2015-04-24 에스케이텔레콤 주식회사 햅텐 및 이에 결합하는 항체를 레퍼런스 항체로 이용하는 면역학적 측정 방법 및 상기 레퍼런스 항체를 이용한 면역학적 측정장치
CN110054620B (zh) * 2019-04-19 2021-01-26 北京九强生物技术股份有限公司 一种苯巴比妥衍生物及其在免疫检测中的用途
CN111875587B (zh) * 2020-07-23 2021-07-13 湖南苏阳医疗科技有限公司 5-氟胞嘧啶衍生物、其制备方法及其在5-氟胞嘧啶免疫检测试剂中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065354A (en) * 1974-10-10 1977-12-27 Syva Company Lysozyme conjugates for enzyme immunoassays
US4092479A (en) * 1976-04-05 1978-05-30 Baxter Travenol Laboratories, Inc. Labeled 5,5-diphenylhydantoin derivatives for radioimmunoassay
US4182856A (en) * 1978-04-25 1980-01-08 Miles Laboratories, Inc. Reagents for use in binding assays to determine diphenylhydantoin
US4244939A (en) * 1978-06-12 1981-01-13 Baxter Travenol Laboratories, Inc. Barbituric acid tracers and their preparation
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4670381A (en) * 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
EP0386644B1 (de) * 1989-03-10 1997-06-04 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Reagenzien zum Nachweis von Drogen

Also Published As

Publication number Publication date
DE69232162T2 (de) 2002-07-11
DE69232162D1 (de) 2001-12-06
EP0517325A2 (de) 1992-12-09
US5284948A (en) 1994-02-08
JPH0627107A (ja) 1994-02-04
EP0517325A3 (en) 1993-04-07
EP0517325B1 (de) 2001-10-31
JP3190728B2 (ja) 2001-07-23

Similar Documents

Publication Publication Date Title
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
FI895228A0 (fi) Integrerad optisk anordning foer maetning av brytningsindex hos vaetskan.
DE3866938D1 (de) Steroid-5-alpha-reduktase-inhibitoren.
FI88411B (fi) Anordning foer upphaengning och behandling av skivformade kroppar
ATE214698T1 (de) Neue carbamazepin hapten analoge
ATE208042T1 (de) Hapten-analoge zur verwendung in immunoassays
FR2612924B1 (fr) Derives de tetrazole antihypercholesterolemiques
FI924478L (fi) 24-oxa-derivat i vitamin d-serien
DE69232002D1 (de) Immunoassays unter Verwendung von markierten Hapten-Analogen
ES2117654T3 (es) Antagonistas de colecistoquinina.
FI894995A0 (fi) System foer hindrande av fiffell i anvaendning av en taxameter.
FI881413A0 (fi) Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
ITBO910198A1 (it) Metodo e dispositivo per il controllo dell'integrita' esteriore di sigarette.
DK448288A (da) Ethanolaminderivater
DE69232001D1 (de) Markierte Hapten-Analoge zur Verwendung in Immunoassays
DK702188D0 (da) Ethanolaminderivater
DK273990D0 (da) Paavisning af modtagelighed for sygdom
KR940007167U (ko) 유골용 봉합
DE3787471D1 (de) 4"-Desoxy-3"-demethoxy-3"-methylen-desmycosin-Derivate.
FI923891A0 (fi) Anordning foer separering och uppradning av moroetter.
IT9043523A0 (it) Pendoli acceleratori
IT1217431B (it) Dispositivo elettronico ausiliario per l'esecuzione di brani musicali
ITLE920004A0 (it) "testi"
BR8703239A (pt) Gerador eletronico estabilizado
DK594189A (da) Anti-hcg-antistoffer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties